Evidence brief · printable

Fibromyalgia evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Fibromyalgia: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/fibromyalgia.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Esreboxetine 2 trials
  • Milnacipran 2 trials
  • Pregabalin 2 trials
  • ABM (see NCT05905159) 1 trial
  • Acetaminophen 1 trial
  • Botulinum Toxin A Injection 1 trial

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Transcranial brain stimulation (tDCS, TMS) 40 trials · 21 completed · 4 with results
  • Yoga, tai chi, qigong and pilates 24 trials · 15 completed · 2 with results
  • Psychotherapy, counselling and peer support 10 trials · 7 completed · 2 with results
  • Education, coaching and self-management 36 trials · 27 completed · 1 with results
  • Mindfulness, meditation and relaxation 31 trials · 22 completed · 1 with results
  • Aerobic and endurance exercise 25 trials · 15 completed · 1 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Magnesium
  • Vitamin D3
  • Chlorella
  • Coenzyme Q10
  • L-Carnitine
  • Saffron

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Mechanism Study of Yangyin Roujin Formula in the Treatment of Fibromyalgia Syndrome NCT07736144
  • Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal… NCT07398417
  • The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With… NCT07186751
  • Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine:… NCT07203339
  • Fibromyalgia Sleep A to ZZZ Study NCT06567886
  • Self-guided Acceptance and Commitment Therapy-based Digital Smartphone Application… NCT05962437

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 9 trials of breathing and respiratory training found, none measured symptom severity and disease activity 74 trials of other approaches did
  • Among 9 trials of breathing and respiratory training found, none measured quality of life 45 trials of other approaches did
  • Among 27 trials of rehabilitation and therapy services found, none measured sleep 30 trials of other approaches did
  • Exercise and physical activity: symptom severity and disease activity 18 trials, no results posted yet
  • Rehabilitation and therapy services: pain 18 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (474 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.